RBCC Developing New Tech to Help Prevent Deaths from Prescription Overdoses

Rainbow Biosciences and TheraKine are developing an injectable, sustained-release technology to improve patients’ use of naltrexone. This summer, Rainbow Coral Corporation will focus on demonstrating the new technology’s readiness for market….rest of article

From the Wall Street Journal July 2, 2014 edition.